Found 6 matching trials
Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct Adenocarcinoma PHASE2 It is a single arm, open-label, phase II cinical trial to evaluate the effi...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer PHASE2 A single-arm, single-center phase II trial study to assess the efficacy and...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients PHASE1 This trial is An open-label, multicohort, multicenter clinical study aimed ...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy PHASE2 The purpose of this study is to evaluate the efficacy and safety of Disitam...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer PHASE2 This study will evaluate the efficacy and safety of intravenous RC48-ADC co...
Show More Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing PHASE2 Patients with salivary gland carcinoma were divided into groups according t...
Show More Learn More & Join Trial